Deutsche Bank
ORKA

Deutsche Bank’s Oruka Therapeutics ORKA Stock Holding History

Deutsche Bank’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Buy
195,204
+54,415
+39% +$3.63M 0.01% 877
2026
Q1 		$6.91M Buy
140,789
+21,460
+18% +$746K ﹤0.01% 1170
2025
Q4 		$3.62M Buy
119,329
+97,210
+439% +$2.71M ﹤0.01% 1474
2025
Q3 		$425K Buy
22,119
+2,758
+14% +$40.9K ﹤0.01% 2641
2025
Q2 		$217K Buy
+19,361
New +$202K ﹤0.01% 2921
2020
Q2 		– Sell
-233
Closed -$8K – 4500
2020
Q1 		$8K Buy
233
+48
+26% +$2.61K ﹤0.01% 4090
2019
Q4 		$12K Buy
+185
New +$11.8K ﹤0.01% 4457
2018
Q2 		– Sell
-1,630
Closed -$175K – 5650
2018
Q1 		$175K Buy
1,630
+1,606
+6,692% +$431K ﹤0.01% 4257
2017
Q4 		$6K Sell
24
-386
-94% -$112K ﹤0.01% 4848
2017
Q3 		$101K Buy
410
+131
+47% +$46.6K ﹤0.01% 4165
2017
Q2 		$144K Buy
279
+65
+30% +$33.9K ﹤0.01% 4079
2017
Q1 		$117K Buy
214
+1
+0.5% +$558 ﹤0.01% 3842
2016
Q4 		$131K Buy
213
+38
+22% +$20.2K ﹤0.01% 3937
2016
Q3 		$106K Hold
175
– – ﹤0.01% 3921
2016
Q2 		$109K Hold
175
– – ﹤0.01% 4067
2016
Q1 		$130K Hold
175
– – ﹤0.01% 3862
2015
Q4 		$175K Buy
175
+59
+51% +$66.8K ﹤0.01% 3786
2015
Q3 		$124K Buy
116
+103
+792% +$157K ﹤0.01% 4005
2015
Q2 		$23K Buy
+13
New +$17.1K ﹤0.01% 4877
2014
Q1 		– Sell
-232
Closed -$589K – 5822
2013
Q4 		$589K Buy
232
+180
+346% +$415K ﹤0.01% 2990
2013
Q3 		$125K Buy
52
+44
+550% +$91.7K ﹤0.01% 4340
2013
Q2 		$16K Buy
+8
New +$24.4K ﹤0.01% 4823

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deutsche Bank's ORKA Position: Q2 2026 in Review

Deutsche Bank increased its Oruka Therapeutics (ORKA) stake by 39% in Q2 2026, buying an estimated $3.63M and bringing the position to 195,204 shares worth $18.6M. The position accounts for 0.01% of the portfolio, ranked #877.

Deutsche Bank first reported a position in ORKA in Q2 2013 and has held it in 22 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Deutsche Bank held 195,204 shares of Oruka Therapeutics worth $18.6M as of Q2 2026.
  • Deutsche Bank bought 54,415 Oruka Therapeutics shares in Q2 2026, an estimated $3.63M.
  • Oruka Therapeutics made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #877 holding.
  • Deutsche Bank first reported a position in Oruka Therapeutics in Q2 2013 and has held it in 22 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.